Joshua T. Brumm
CEO & DirectorMr. Joshua T. Brumm, also known as Josh, is Chief Executive Officer & Director of Crescent Biopharma, Inc. from March 2025. He is Chairman of Amphista Therapeutics Limited. He is Director of AIRNA Corporation, Inc. from July 2024. He is Venture Partner of Forbion Capital Partners B.V. from 2025. He joined the Forbion Capital Partners B.V. in June 2024. He was General Partner of Forbion Capital Partners B.V. from June 2024 to 2025. He was Principal Financial Officer, Principal Accounting Officer and Executive VP of Finance of Pharmacyclics LLC. He joined the Pharmacyclics LLC on August 14, 2012. He was Chief Financial Officer, Principal Accounting Officer and Senior Vice President of ZELTIQ Aesthetics, Inc. He was employed at ZELTIQ Aesthetics, Inc. until August 08, 2012. He was COO & CFO of Aravive, Inc. until December 01, 2017. He was employed at Aravive, Inc. from November 2013 to December 31, 2017. He was Adviser of Kaleido Biosciences, Inc. from October 11, 2019 to December 31, 2019. He was COO & CFO of Kaleido Biosciences, Inc. from August 2018 to October 11, 2019. He was employed at Kaleido Biosciences, Inc. until December 31, 2019. He was Advisor of Atlas Venture L.P. from July 2021 to 2024. He was employed at Atlas Venture L.P. until 2024. He was CEO, President & Director of Dyne Therapeutics, Inc. from October 2019 to March 2024. He was President, CEO, Treasurer, Secretary & Director of Dyne Therapeutics, Inc. He was employed at Dyne Therapeutics, Inc. until March 2024. Josh successfully led the company through its initial public offering and advanced several rare muscle disease programs to positive clinical proof-of-concept data. Mr. Brumm has a rich background in finance and operations. He led the company through its IPO and the international product launch for CoolSculpting. His experience extends to roles such as Director of Finance at Proteolix, Inc. and various positions in investment banking at Citigroup Global Markets and Morgan Stanley. Throughout his career, Mr. Brumm has successfully led several companies to public listings, held senior leadership positions in three companies that were acquired and raised capital. He has been recognized as Silicon Valley Business Journal’s CFO of the Year in 2014. He has extensive experience in building and leading companies in biotech and healthcare. Prior to Dyne, he held leadership roles at several other biotechs, including Proteolix, Pharmacyclics and ZELTIQ Aesthetics. He has B.A. in Business Administration from University of Notre Dame du Lac.
Positions
- Company NameCrescent Biopharma, Inc.Stock CodeCBIOPositionCEO & DirectorColleagues
- PEPeter Evan HarwinIndependent Chairman
- JMJonathan McNeillPresident & COO
- EIEllie ImChief Medical Officer
- RWRichard William ScalzoChief Financial Officer
- RLRyan LynchSenior VP of Finance, Treasurer & Chief Accounting Officer
- ABAlexandra BalcomIndependent Director
- DCDavid Charles LubnerIndependent Director
- JVJonathan ViolinDirector
